These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

629 related articles for article (PubMed ID: 33648498)

  • 1. CircWAC induces chemotherapeutic resistance in triple-negative breast cancer by targeting miR-142, upregulating WWP1 and activating the PI3K/AKT pathway.
    Wang L; Zhou Y; Jiang L; Lu L; Dai T; Li A; Chen Y; Zhang L
    Mol Cancer; 2021 Mar; 20(1):43. PubMed ID: 33648498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hsa_circ_0000199 facilitates chemo-tolerance of triple-negative breast cancer by interfering with miR-206/613-led PI3K/Akt/mTOR signaling.
    Li H; Xu W; Xia Z; Liu W; Pan G; Ding J; Li J; Wang J; Xie X; Jiang D
    Aging (Albany NY); 2021 Jan; 13(3):4522-4551. PubMed ID: 33495420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The circRNA circIFI30 promotes progression of triple-negative breast cancer and correlates with prognosis.
    Xing L; Yang R; Wang X; Zheng X; Yang X; Zhang L; Jiang R; Ren G; Chen J
    Aging (Albany NY); 2020 Jun; 12(11):10983-11003. PubMed ID: 32497020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The circRNA circAGFG1 acts as a sponge of miR-195-5p to promote triple-negative breast cancer progression through regulating CCNE1 expression.
    Yang R; Xing L; Zheng X; Sun Y; Wang X; Chen J
    Mol Cancer; 2019 Jan; 18(1):4. PubMed ID: 30621700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. circGFRA1 affects the sensitivity of triple-negative breast cancer cells to paclitaxel via the miR-361-5p/TLR4 pathway.
    Zheng SR; Huang QD; Zheng ZH; Zhang ZT; Guo GL
    J Biochem; 2021 Jul; 169(5):601-611. PubMed ID: 33481008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer.
    Zheng X; Huang M; Xing L; Yang R; Wang X; Jiang R; Zhang L; Chen J
    Mol Cancer; 2020 Apr; 19(1):73. PubMed ID: 32264877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WBP2 Downregulation Inhibits Proliferation by Blocking YAP Transcription and the EGFR/PI3K/Akt Signaling Pathway in Triple Negative Breast Cancer.
    Song H; Wu T; Xie D; Li D; Hua K; Hu J; Fang L
    Cell Physiol Biochem; 2018; 48(5):1968-1982. PubMed ID: 30092563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ZNF460-mediated circRPPH1 promotes TNBC progression through ITGA5-induced FAK/PI3K/AKT activation in a ceRNA manner.
    Zhang C; Yu Z; Yang S; Liu Y; Song J; Mao J; Li M; Zhao Y
    Mol Cancer; 2024 Feb; 23(1):33. PubMed ID: 38355583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CircDUSP1 regulates tumor growth, metastasis, and paclitaxel sensitivity in triple-negative breast cancer by targeting miR-761/DACT2 signaling axis.
    Huang S; Xie J; Lei S; Fan P; Zhang C; Huang Z
    Mol Carcinog; 2023 Apr; 62(4):450-463. PubMed ID: 36562476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. circKIF4A acts as a prognostic factor and mediator to regulate the progression of triple-negative breast cancer.
    Tang H; Huang X; Wang J; Yang L; Kong Y; Gao G; Zhang L; Chen ZS; Xie X
    Mol Cancer; 2019 Feb; 18(1):23. PubMed ID: 30744636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circ-RNF111 contributes to paclitaxel resistance in breast cancer by elevating E2F3 expression via miR-140-5p.
    Zang H; Li Y; Zhang X; Huang G
    Thorac Cancer; 2020 Jul; 11(7):1891-1903. PubMed ID: 32445273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. lncRNA GAS5-promoted apoptosis in triple-negative breast cancer by targeting miR-378a-5p/SUFU signaling.
    Zheng S; Li M; Miao K; Xu H
    J Cell Biochem; 2020 Mar; 121(3):2225-2235. PubMed ID: 31692053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circular RNA circ-ZEB1 acts as an oncogene in triple negative breast cancer via sponging miR-448.
    Pei X; Zhang Y; Wang X; Xue B; Sun M; Li H
    Int J Biochem Cell Biol; 2020 Sep; 126():105798. PubMed ID: 32629026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circ_0000520 contributes to triple-negative breast cancer progression through mediating the miR-1296/ZFX axis.
    Zhou Y; Ma G; Peng S; Tuo M; Li Y; Qin X; Yu Q; Kuang S; Cheng H; Li J
    Thorac Cancer; 2021 Sep; 12(18):2427-2438. PubMed ID: 34324278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CircWHSC1 regulates malignancy and glycolysis by the miR-212-5p/AKT3 pathway in triple-negative breast cancer.
    Ding L; Xie Z
    Exp Mol Pathol; 2021 Dec; 123():104704. PubMed ID: 34624276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. circGFRA1 and GFRA1 act as ceRNAs in triple negative breast cancer by regulating miR-34a.
    He R; Liu P; Xie X; Zhou Y; Liao Q; Xiong W; Li X; Li G; Zeng Z; Tang H
    J Exp Clin Cancer Res; 2017 Oct; 36(1):145. PubMed ID: 29037220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. circRAD18 sponges miR-208a/3164 to promote triple-negative breast cancer progression through regulating IGF1 and FGF2 expression.
    Zou Y; Zheng S; Xiao W; Xie X; Yang A; Gao G; Xiong Z; Xue Z; Tang H; Xie X
    Carcinogenesis; 2019 Dec; 40(12):1469-1479. PubMed ID: 31001629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circ-TFCP2L1 Promotes the Proliferation and Migration of Triple Negative Breast Cancer through Sponging miR-7 by Inhibiting PAK1.
    Wang Q; Li Z; Hu Y; Zheng W; Tang W; Zhai C; Gu Z; Tao J; Wang H
    J Mammary Gland Biol Neoplasia; 2019 Dec; 24(4):323-331. PubMed ID: 31776835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular RNA circPTK2 modulates migration and invasion via miR-136/NFIB signaling on triple-negative breast cancer cells in vitro.
    Wang M; Chen D; Zhang H; Luo C
    Inflamm Res; 2022 Apr; 71(4):409-421. PubMed ID: 35234989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of miR-361-5p in triple-negative breast cancer (TNBC) inhibits migration and invasion by targeting RQCD1 and inhibiting the EGFR/PI3K/Akt pathway.
    Han J; Yu J; Dai Y; Li J; Guo M; Song J; Zhou X
    Bosn J Basic Med Sci; 2019 Feb; 19(1):52-59. PubMed ID: 29924958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.